Just a few short years after coming to market, the latest GLP-1 drugs are showing versatility in battling diseases related to diabetes and obesity, lifting the fortunes and expectations for market leaders Novo Nordisk Other factors will also increase demand and exacerbate the shortages, further limiting access to the drugs. In March, Novo's Wegovy was approved by the FDA for those with cardiovascular disease and risk of heart attack and death.
With more opportunity down the pike, that could fulfill analyst predictions of a $100-billion-plus market for the GLP-1 category. It will all add up to a very expensive future, he said. One that the federal government is trying to fight.
Eli Lilly Diabetes Drugs Weight Loss David Ricks David Risinger
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman SaysThe weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S to record peaks is raising the stakes for investors, according to Goldman Sachs Group Inc. analysts.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Eli Lilly's weight loss drug could help sleep apnea patientsShares of Eli Lilly (LLY) are slightly above their flatline Wednesday morning after the pharmaceutical giant announced positive results from a clinical trial...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Weight-loss drug shortage result of 'unprecedented demand'Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Weight loss drugs and the many use cases in medical treatmentsNovo Nordisk's (NVO) Ozempic and Wegouvy and Eli Lilly's (LLY) Zepbound are the leading names in the latest GLP-1 weight loss drug cycle, a trend that has...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
China Vanke Seeks to Sell 21.4% Stake in Logistics Operator GLPChina Vanke Co. is seeking to sell its entire stake in logistics firm GLP Pte, according to people familiar with the matter, as the state-backed developer seeks to amass cash to stave off a debt crisis.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
China Vanke seeks to offload stake in logistics operator GLP, Bloomberg reportsExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »